Evaluating RISQ System Implementation in Acutely Malnourished Children in Chad (CRIMSON)

Launched by THE HOSPITAL FOR SICK CHILDREN · Nov 2, 2023

Keywords

ClinConnect Summary

The CRIMSON clinical trial is studying how a special system called the Responses to Illness Severity Quantification (RISQ) can help improve care for young children with severe acute malnutrition in Ngouri, Chad. The goal is to see if using this system can lower the number of children who sadly do not survive and to make the treatment process more effective for children between 6 months and 5 years old. The trial is currently recruiting participants, and both children and healthcare staff can be involved.

To be eligible for the study, children must be between 6 to 59 months old and must have permission from a parent or guardian to participate. However, children with allergies to milk, peanuts, or certain therapeutic foods cannot join the study. Participants in this trial can expect to receive care through the OptiMA program, which focuses on treating malnutrition. This study will help researchers understand how to improve treatment for these vulnerable children and ultimately save lives.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Children:
• • 1. age: 6 to 59 months at enrolment on the day of their admission/re-admission to the OptiMA program
• • 2. written consent to participate
• Front line staff providing care to patients enrolled in the Optima program:
• • \[1\] Registered Nurses \[2\] Medical Doctors
• Exclusion Criteria:
• Children:
• • 1. Children allergic to milk, peanuts and/or ready-to-use therapeutic food (RUTF)
• • 2. Children not residing in one of the study areas.